The Immunogenicity and Properties of a Whole-Cell ETEC Vaccine Inactivated with Psoralen and UVA Light in Comparison to Formalin
2023
Marlena M. Westcott | Maria Blevins | Thomas F. Wierzba | Alexis E. Morse | Kinnede R. White | Leigh Ann Sanders | John W. Sanders
Inactivated whole-cell vaccines present a full repertoire of antigens to the immune system. Formalin treatment, a standard method for microbial inactivation, can modify or destroy protein antigenic epitopes. We tested the hypothesis that photochemical inactivation with psoralen and UVA light (PUVA), which targets nucleic acid, would improve the immunogenicity of an Enterotoxigenic E. coli (ETEC) vaccine relative to a formalin-inactivated counterpart. Exposure of ETEC H10407 to PUVA using the psoralen drug 4&prime:-Aminomethyltrioxsalen hydrochloride (AMT) yielded replication-incompetent bacteria that retained their metabolic activity. CFA/I-mediated mannose-resistant hemagglutination (MRHA) was equivalent for PUVA-inactivated and live ETEC, but was severely reduced for formalin&ndash:ETEC, indicating that PUVA preserved fimbrial protein functional integrity. The immunogenicity of PUVA&ndash:ETEC and formalin&ndash:ETEC was compared in mice ±: double mutant heat-labile enterotoxin (dmLT) adjuvant. Two weeks after an intramuscular prime/boost, serum anti-ETEC IgG titers were similar for the two vaccines and were increased by dmLT. However, the IgG responses raised against several conserved ETEC proteins were greater after vaccination with PUVA&ndash:ETEC. In addition, PUVA&ndash:ETEC generated IgG specific for heat-labile toxin (LT) in the absence of dmLT, which was not a property of formalin&ndash:ETEC. These data are consistent with PUVA preserving ETEC protein antigens in their native-like form and justify the further testing of PUVA as a vaccine platform for ETEC using murine challenge models.
显示更多 [+] 显示较少 [-]